Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Tables)

v3.23.1
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Shares of Common Stock That May Potentially Be Issued in the Future All shares of Common Stock that may potentially be issued in the future are as follows:
Year Ended December 31,
2022 2021
Common Stock Warrants 1,597,606 168,932
Employee Stock Options 84,751 12,954
Restricted Stock 30,000 375
Preferred Stock 52 52
Total Shares of Common Stock Issuable 1,712,409 182,313
Schedule of Business Acquisitions by Acquisition, Contingent Consideration Below is the list of obligations for each relevant transaction are as of December 31, 2022 as follows:
Acquisition Milestone Achievement Condition Contingent Consideration Payable
Bayon  
Successful completion of Phase 1b $ 0.5  million
Successful completion of Phase 2 $ 1.0  million
Successful completion of Phase 3 $ 4.0  million
FDA approval $ 1.7  million
Panoptes  
Beginning of Phase 3 $ 4.8  million
FDA approval $ 4.8  million
Jade  
FDA approval $ 2.2  million